成人单份脐血移植后植入前综合征的危险因素及其对移植结局的影响
基于日本全国数据库分析3734例成人单份脐血移植,植入前综合征(PES)发生率为18.3%,危险因素包括较高的造血干细胞移植合并症指数、首次移植、清髓性预处理、较低的总有核细胞剂量及不含他克莫司联合甲氨蝶呤的GVHD预防方案。PES与II-IV级急性GVHD和慢性GVHD发生率升高相关,并独立增加非复发死亡、降低复发,总生存有劣于无PES的趋势。
要点
- PES发生于18.3%的成人单份脐血移植患者。
- PES独立增加非复发死亡(HR 1.46),降低复发(HR 0.78),总生存有劣于无PES的趋势(HR 1.13)。
- PES合并急性GVHD者2年非复发死亡最高(31.7%)、总生存最低(55.9%)。
核心结论
- PES是成人单份脐血移植后常见的早期并发症,对移植结局有持久影响,PES与急性GVHD并存时结局最差。
研究设计与样本
- 基于日本全国数据库的回顾性分析,纳入3734例接受单份脐血移植的成人患者。
主要发现
- PES发生率为18.3%。
- PES危险因素包括较高的造血干细胞移植合并症指数、首次移植、清髓性预处理、较低的总有核细胞剂量及不含他克莫司联合甲氨蝶呤的GVHD预防方案。
- PES组II-IV级急性GVHD发生率为53.1%,无PES组为31.3%(p < 0.001)。
- PES组慢性GVHD发生率为27.2%,无PES组为21.7%(p = 0.002)。
- 多因素校正后PES独立增加非复发死亡(HR 1.46;95% CI 1.22-1.75;p < 0.001),降低复发(HR 0.78;95% CI 0.63-0.96;p = 0.020),总生存有劣于无PES的趋势(HR 1.13;95% CI 0.98-1.30;p = 0.088)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pre-engraftment syndrome (PES) is a unique complication of cord blood transplantation (CBT) whose risk factors and impact on transplant outcomes remain controversial. Using a nationwide database in Japan, we analyzed a total of 3734 patients who underwent single-unit CBT. PES occurred in 18.3% of patients, and risk factors for PES included a higher hematopoietic cell transplantation-specific comorbidity index, first transplantation, myeloablative conditioning (MAC), lower total nucleated cell (TNC) dose, and graft-versus-host disease (GVHD) prophylaxis regimens excluding tacrolimus with methotrexate. Patients who developed PES had significantly higher incidences of grade II-IV acute GVHD (53.1% vs. 31.3%, p < 0.001) and chronic GVHD (27.2% vs. 21.7%, p = 0.002) compared to those without PES. Landmark analysis with multivariable adjustment revealed that PES was independently associated with increased non-relapse mortality (NRM, hazard ratio [HR] 1.46; 95% CI 1.22-1.75; p < 0.001), reduced relapse incidence (HR 0.78; 95% CI 0.63-0.96; p = 0.020), and a trend toward inferior overall survival (OS, HR 1.13; 95% CI 0.98-1.30; p = 0.088). Moreover, patients who experienced both PES and acute GVHD had the highest 2-year NRM (31.7%; 95% CI 26.0%-37.6%) and the lowest 2-year OS (55.9%; 95% CI 50.0%-62.4%), compared with those who experienced either PES (NRM 20.7%; OS 65.0%) or acute GVHD (NRM 19.5%; OS 62.8%) (p < 0.001), highlighting the combined effects of these complications. This study, the largest to date on PES, demonstrates its clinical significance as an early complication with lasting effects on transplant outcomes.
引用
- Sakurai M, Kataoka K, Mizuno K, et al. Risk Factors for and Impact of Pre-Engraftment Syndrome on Outcomes Following Single-Unit Cord Blood Transplantation in Adults. Am J Hematol. 2025. PMID: 41002003. doi:10.1002/ajh.70094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。